No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annualized revenue (TTM) · by quarter, last 14
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Autonomix Medical, Inc. (AMIX) stock was $3.54 as of Oct 5, 2026, 4:00 PM EDT, down 6.35% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -85.1%
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Medical - Devices · The Woodlands, TX
Next Earnings Date
Nov 11, 2026
36 days away
EPS Estimate
-6.20
Revenue Est.
N/A
Last Quarter Results
EPS
$-5.02
vs Estimate
$-6.40
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AMIX | $1.92M | $3.54 | -6.35% | -85.08% | N/A | N/A | N/A |
| 2CRIS | $1.54M | $0.79 | -1.79% | -97.57% | -81.06% | -59.09% | vs AMIX |
| 3ELAB | $1.49M | $3.27 | -2.68% | -99.94% | N/A | N/A | vs AMIX |
| 4CELZ | $2.37M | $0.92 | -2.79% | -71.43% | -57.96% | -72.19% | vs AMIX |
| 5FBLG | $2.47M | $1.18 | -4.84% | -89.14% | N/A | N/A | vs AMIX |
| 6ARTL | $1.36M | $3.51 | -4.62% | -91.59% | -64.27% | N/A | vs AMIX |
forward FY estimate
N/A
$0.00
vs Estimate
$0.00
Consensus Rating
Based on 2 analysts
Average Price Target
$58.80
+1561.0% upside
Low
$42.00
Current
$3.54
High
$75.60
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-6.51 | $-6.20 | $-5.88 | 2 |
| Quarter ending Dec 2026 | $-5.46 | $-5.36 | $-5.25 | 2 |
| Quarter ending Mar 2027 | $-5.14 | $-5.14 | $-5.14 | 1 |
| Quarter ending Jun 2027 | $-5.46 | $-5.46 | $-5.46 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $-22.68 | $-22.68 | $-22.68 | 1 |
| FY 2028 | $-19.53 | $-19.53 | $-19.53 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.00 | $0.00 | $0.00 | 0 |
| Quarter ending Dec 2026 | $0.00 | $0.00 | $0.00 | 0 |
| Quarter ending Mar 2027 | $0.00 | $0.00 | $0.00 | 0 |
| Quarter ending Jun 2027 | $0.00 | $0.00 | $0.00 | 0 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $0.00 | $0.00 | $0.00 | 0 |
| FY 2028 | $900000.00 | $900000.00 | $900000.00 | 1 |
